Impairments across multiple domains are a disabling consequence of multiple sclerosis (MS). Originating from preventive medical strategies, the “time matters”-perspective has become a focal point when treating MS. In particular, early detection of physical and cognitive deficits, along with deficits in patient-reported outcomes seems crucial to further optimize both pharmacological and non-pharmacological MS treatment strategies. Therefore, this topical review investigates the level of impairments across multiple domains (physical function, cognitive function, and patient-reported outcomes) in the early stage of MS (⩽5 years since diagnosis, including clinically isolated syndrome (CIS)), when compared to matched healthy controls. Even at early disease stages, studies show impairments corresponding to 8%–34% and small-to-large numerical effect sizes (0.35–2.85) in MS/CIS patients across domains. This evidence call for early screening programs along with early interventions targeting the multiple impaired domains. This further highlights the importance of preventive initiatives preserving and/or restoring physical and cognitive reserve capacity if possible.
KisterIBaconTEChamotE, et al. Natural history of multiple sclerosis symptoms. Int J MS Care2013; 15: 146–158.
2.
Hilt PflegerCCMeulengracht FlachsEKoch- HenriksenN. Social consequences of multiple sclerosis (1): Early pension and temporary unemployment—a historical prospective cohort study. Mult Scler J2009; 16: 121–126.
3.
StenagerEStenagerENKnudsenL, et al. Multiple sclerosis: The impact on family and social life. Acta Psychiatr Belg1994; 94: 165–174.
4.
SkokouMSoubasiEGourzisP. Depression in multiple sclerosis: A review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurol2012; 2012: 427102.
5.
ErlangsenAStenagerEConwellY, et al. Association between neurological disorders and death by suicide in Denmark. Jama2020; 323: 444–454.
6.
AgiusMMengXChinP, et al. Fingolimod therapy in early multiple sclerosis: An efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom. CNS Neurosci Ther2014; 20: 446–451.
7.
ComiGFilippiMBarkhofF, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study. Lancet2001; 357: 1576–1582.
8.
GiovannoniGButzkuevenHDhib-JalbutS, et al. Brain health: Time matters in multiple sclerosis. Multiple Sclerosis and Related Disorders2016; 9(Suppl. 1): S5–S48.
9.
CerqueiraJJCompstonDASGeraldesR, et al. Time matters in multiple sclerosis: Can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?J Neurol Neurosurg Psychiatry2018; 89: 844–850.
10.
RiemenschneiderMHvidLGStenagerE, et al. Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation. Mult Scler2018; 24: 886–894.
11.
BenedettiMGPipernoRSimonciniL, et al. Gait abnormalities in minimally impaired multiple sclerosis patients. Mult Scler1999; 5: 363–368.
12.
BjartmarCKinkelRPKiddG, et al. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology2001; 57: 1248–1252.
13.
MartinCLPhillipsBAKilpatrickTJ, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler2006; 12: 620–628.
14.
SteenhofMStenagerENielsenNM, et al. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases. Mult Scler Relat Disord2019; 32: 97–102.
15.
SiepmanTAJanssensACde KoningI, et al. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol2008; 255: 910–916.
16.
RamariCMoraesAGTauilCB, et al. Knee flexor strength and balance control impairment may explain declines during prolonged walking in women with mild multiple sclerosis. Mult Scler Relat Disord2018; 20: 181–185.
17.
Bosnak-GucluMGunduzAGNazlielB, et al. Comparison of functional exercise capacity, pulmonary function and respiratory muscle strength in patients with multiple sclerosis with different disability levels and healthy controls. J Rehabil Med2012; 44: 80–86.
18.
KalronAAchironADvirZ. Muscular and gait abnormalities in persons with early onset multiple sclerosis. J Neurol Phys Ther2011; 35: 164–169.
19.
KalronADvirZAchironA. Effect of a cognitive task on postural control in patients with a clinically isolated syndrome suggestive of multiple sclerosis. Eur J Phys Rehab Med2011; 47: 579–586.
20.
MotlRWCohenJABenedictR, et al. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler2017; 23: 704–710.
21.
BrentonJNKoshiyaHWoolbrightE, et al. The multiple sclerosis functional composite and symbol digit modalities test as outcome measures in pediatric multiple sclerosis. Mult Scler J Exp Transl Clin2019; 5: 2055217319846141.
22.
HeesenCBohmJReichC, et al. Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuable. Mult Scler2008; 14: 988–991.
23.
GreenRCutterGFriendlyM, et al. Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?Mult Scler J2017; 3: 2055217317728301.
24.
SalterARCutterGRTyryT, et al. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin2010; 26: 493–500.
25.
AmatoMPPonzianiGPracucciG, et al. Cognitive impairment in early-onset multiple sclerosis: Pattern, predictors, and impact on everyday life in a 4-year follow-up. Archiv Neurol1995; 52: 168–172.
26.
AmatoMPPortaccioEGorettiB, et al. Relevance of cognitive deterioration in early relapsing-remitting MS: A 3-year follow-up study. Mult Scler2010; 16: 1474–1482.
27.
Baysal KiracLEkmekciOYuceyarN, et al. Assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis. Behav Neurol2014; 2014: 637694.
28.
BonnetMCDeloireMSSalortE, et al. Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis. J Neurol Sci2006; 251: 23–28.
29.
DeloireMSSalortEBonnetM, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry2005; 76: 519–526.
30.
FeuilletLReuterFAudoinB, et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler2007; 13: 124–127.
31.
LandrøNISletvoldHCeliusEG. Memory functioning and emotional changes in early phase multiple sclerosis. Archiv Clin Neuropsychol2000; 15: 37–46.
32.
Lopez- GongoraMEscartinAMartinez- HortaS, et al. Neurophysiological evidence of compensatory brain mechanisms in early-stage multiple sclerosis. PLoS ONE2015; 10: e0136786.
33.
PitteriMZiccardiSDaporC, et al. Lost in classification: Lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients. Brain Sci2019; 9: 321.
34.
SchulzDKoppBKunkelA, et al. Cognition in the early stage of multiple sclerosis. J Neurol2006; 253: 1002–1010.
35.
KalronADvirZAchironA. Walking while talking—Difficulties incurred during the initial stages of multiple sclerosis disease process. Gait Posture2010; 32: 332–335.
36.
AudoinBAu DuongMVRanjevaJP, et al. Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp2005; 24: 216–228.
37.
BethuneATipuVSledJG, et al. Diffusion tensor imaging and cognitive speed in children with multiple sclerosis. J Neurol Sci2011; 309: 68–74.
38.
MarstrandLOsterbergOWalstedT, et al. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS. Mult Scler Relat Disord2019; 37: 101458.
39.
CharvetLEBeekmanRAmadiumeN, et al. The symbol digit modalities test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). J Neurol Sci2014; 341: 79–84.
40.
CrivelliLFarezMFGonzalezCD, et al. Alerting network dysfunction in early multiple sclerosis. J Int Neuropsychol Soc2012; 18: 757–763.
41.
HyncicovaEKalinaAVyhnalekM, et al. Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome. PLoS ONE2018; 13: e0200254.
42.
PlancheVRuetACharré -MorinJ, et al. Pattern separation performance is decreased in patients with early multiple sclerosis. Brain Behavior2017; 2017: 7.
43.
De StefanoNGiorgioABattagliniM, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology2010; 74: 1868–1876.
44.
ReuterFZaaraouiWCrespyL, et al. Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis. J Neurol Neurosurg Psychiatry2011; 82: 1157–1159.
45.
MarrieRAHorwitzRCutterG, et al. The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreated. Mult Scler2009; 15: 385–392. DOI: 10.1177/1352458508099477
46.
BinzerSMcKayKABrennerP, et al. Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study. Neurology2019; 93: e2216–e2223.
47.
FiskJDPontefractARitvoPG, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci1994; 21: 9–14.
48.
AsanoMFinlaysonML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: Exercise, education, and medication. Mult Scler Int2014; 2014: 798285.
49.
Moss-MorrisRHarrisonAMSafariR, et al. Which behavioural and exercise interventions targeting fatigue show the most promise in multiple sclerosis? A systematic review with narrative synthesis and meta-analysis. Behav Res Ther2019; 2019: 103464.
50.
PutzkiNFischerJGottwaldK, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol2009; 16: 713–720.
51.
ZiemssenTDerfussTde StefanoN, et al. Optimizing treatment success in multiple sclerosis. J Neurol2016; 263: 1053–1065.
52.
BrandstadterRKatz SandISumowskiJF. Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis. Mult Scler2019; 25: 1372–1378.
53.
PiluttiLAPlattaMEMotlRW, et al. The safety of exercise training in multiple sclerosis: A systematic review. J Neurol Sci2014; 343: 3–7.
54.
MotlRWSandroffBM. Benefits of exercise training in multiple sclerosis. Curr Neurol Neurosci Rep2015; 15: 62.
55.
MotlRWSandroffBMKwakkelG, et al. Exercise in patients with multiple sclerosis. Lancet Neurol2017; 16: 848–856.
56.
DalgasULangeskov -ChristensenMStenagerE, et al. Exercise as medicine in multiple sclerosis-time for a paradigm shift: Preventive, symptomatic, and disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep2019; 19: 88.
57.
KjolhedeTSiemonsenSWenzelD, et al. Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?Mult Scler2018; 24: 1356–1365.
58.
Katz SandI. The role of diet in multiple sclerosis: Mechanistic connections and current evidence. Curr Nutr Rep2018; 7: 150–160.
59.
GubertCKongGRenoirT, et al. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis2020; 134: 104621.
60.
MischeLJMowryEM. The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: A review. Curr Treat Options Neurol2018; 20: 8.
61.
NautaIMSpeckensAEMKesselsRPC, et al. Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): A study protocol for a randomised controlled trial. BMC Neurology2017; 17: 201.
62.
ChalahMAAyacheSS. Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature. J Clin Neurosci2018; 52: 1–4.
63.
GoveroverYChiaravallotiNDO'BrienAR, et al. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: An updated review of the literature from 2007 to 2016. Archiv Phys Med Rehab2018; 99: 390–407.
64.
EgawaNLokJWashidaK, et al. Mechanisms of axonal damage and repair after central nervous system injury. Transl Stroke Res2017; 8: 14–21.
65.
PitteriMRomualdiCMagliozziR, et al. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler2017; 23: 848–854.
66.
BjornevikKMungerKLCorteseM, et al. Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol2019; 77: 58–64.
67.
Storm van’s GravesandeKBlaschekACalabreseP, et al. Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis. Mult Scler Relat Disord2019; 36: 101368.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
